InvestorsHub Logo
Followers 6
Posts 4111
Boards Moderated 0
Alias Born 12/14/2009

Re: Simple Steve post# 37921

Wednesday, 10/11/2017 4:00:04 PM

Wednesday, October 11, 2017 4:00:04 PM

Post# of 108192
Allergan is paying a stunning 500% premium to buy a clinical-stage biotech

Published: Sept 21, 2016 6:53 a.m. ET

What should a biotech investor make of Allergan PLC’s announcement Tuesday that it had reached an agreement to buy Tobira Therapeutics Inc. at an eye-popping premium of more than 500%?

The news propelled Tobira’s stock a stunning $34, or 721%, higher. It closed at $38.91 to mark its biggest-ever one-day price and percentage gains. The company’s market capitalization has shot up to $732 million from $89 million at Monday’s close.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News